Found 16 matching trials
FT516 and IL2 With Enoblituzumab for Ovarian Cancer
PHASE1This is a single center Phase I clinical trial of FT516 administered intrap...
Location
University of Minnesota, Masonic Cancer Center
FT576 in Subjects With Multiple Myeloma
PHASE1This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Location
University of Alabama at Birmingham
Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
PHASE1This is a single center Phase I clinical trial of FT538 administered intrav...
Location
Masonic Cancer Center at University of Minnesota
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
N/ASubjects who previously took part in the FT500-101 study and received allog...
Location
UCSD Moores Cancer Center
Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia
PHASE1This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Location
Clinical research ethics committee of the first affiliated hospital, college of medicine, zhejiang University
Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia
EARLY_PHASE1This is a clinical study on the use of iNK cells for the treatment of refra...
Location
Guangzhou Ruixin Biotechnology Co., Ltd
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
PHASE1FT500 is an off-the-shelf, iPSC-derived NK cell product that can bridge inn...
Location
UCSD Moores Cancer Center
A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
PHASE1ELiPSE-1 is a Phase 1, multi-center, dose-finding study to evaluate the saf...
Location
Banner MD Anderson Cancer Center
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
PHASE1CALiPSO-1 is a Phase 1, multi-centre, dose-confirmation study to evaluate t...
Status
Active Not Recruiting
Location
Keck School of Medicine of University of Southern California
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
NAThis trial is to investigate the safety, efficacy of iNK in subjects with s...
Location
Multiple Locations